This is the case of peripheral blood CD14+ mononuclear cells of subjects carrying rheumatoid arthritis and coronary artery disease, which display an increased number of MAM contact sites when compared to healthy individuals (Zeisbrich et al., 2018). This evidence concerns the gene CD14 and rheumatoid arthritis.